Entera Bio Ltd
NASDAQ:ENTX
Entera Bio Ltd
NASDAQ:ENTX
Price:
2 USD
-4.31%
Market Closed
Updated:
Jun 10, 2024
Entera Bio Ltd
Total Assets
|
Entera Bio Ltd
Total Assets Peer Comparison
Comparables:
CLGN
KMDA
B
BLRX
URGN
B
BONS
Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Total Assets
$11.8m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Total Assets
$34.1m
|
CAGR 3-Years
47%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
Kamada Ltd
NASDAQ:KMDA
|
Total Assets
$343.2m
|
CAGR 3-Years
18%
|
CAGR 5-Years
19%
|
CAGR 10-Years
10%
|
|
B
|
BioLine RX Ltd
TASE:BLRX
|
Total Assets
$63.9m
|
CAGR 3-Years
11%
|
CAGR 5-Years
3%
|
CAGR 10-Years
12%
|
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Total Assets
$200.6m
|
CAGR 3-Years
27%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Total Assets
₪44.9m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
35%
|
CAGR 10-Years
19%
|
See Also
What is Entera Bio Ltd's Total Assets?
Total Assets
11.8m
USD
11.8m
USD
Based on the financial report for Dec 31, 2023, Entera Bio Ltd's Total Assets amounts to 11.8m USD.
What is Entera Bio Ltd's Total Assets growth rate?
Total Assets CAGR 5Y
-2%
-2%
Over the last year, the Total Assets growth was -10%. The average annual Total Assets growth rates for Entera Bio Ltd have been 5% over the past three years , -2% over the past five years .
You don't have any saved screeners yet
